GNAS and cancer: In addition to oncogenic activation of GNAS, a variety of cancer-associated alterations can enhance GPCR-GNAS-PKA signaling, including activating mutations in the catalytic subunit of PKA, inactivating mutations in the regulatory subunit of PKA, and overexpression of cAMP-stimulating GPCRs70–73.